Zhongtai Securities Co.Ltd(600918) small and medium-sized market research team conducted corresponding sorting and Research on the companies approved by the CSRC for IPO registration in the latest week of gem and science and Innovation Board (202203.21202203.28), and launched the weekly special research report on new shares. This weekly report involves 4 enterprises to be issued on the science and innovation board and 4 enterprises to be issued on the gem:
Gem:
Qiaoyuan gas (300646. SZ): the company is an integrated gas supplier focusing on the R & D, production, sales and service of high-purity gas. The compound annual growth rates of the company’s revenue and net profit from 2017 to 2020 were 11.53% and 25.53% respectively, with outstanding growth capacity. The adjustment and upgrading of the national industrial structure will promote the continuous positive development of the industrial gas field. With the raised investment projects promoting the improvement of the company’s production capacity, the company’s product structure will be further improved, its profitability will be enhanced, and the company will further consolidate its competitive advantage in the industry.
Ruitai new material (a20731. SZ): the company is a supplier of lithium-ion battery materials, silane coupling agents and other new chemical materials. The compound annual growth rates of the company’s revenue and net profit from 2017 to 2020 were 16.60% and 16.29% respectively, and the growth capacity exceeded the average level of comparable companies in the same industry. With the continuous development of the downstream new energy vehicle industry, the application scenarios of consumer batteries are constantly enriched and the energy storage battery market is gradually opened. At the same time, the raised investment projects further strengthen the company’s production capacity, and the company is expected to improve its industry strength and market position.
Qingyan environment (a21052. SZ): the company is a high-tech enterprise focusing on the R & D and application of rapid biochemical sewage treatment technology, providing customers with rpir process package, water treatment operation services and water treatment engineering services. The compound annual growth rates of the company’s revenue and net profit from 2018 to 2020 were 58.59% and 46.97% respectively, and the growth capacity exceeded the average level of comparable companies in the same industry. With the national competent authorities providing various policy guarantees for water environment treatment, and raising investment projects to further strengthen the company’s production capacity and improve the technical level, the company is expected to improve its industry strength and market position.
Purui ophthalmology (a20457. SZ): the ophthalmic general medical services provided by the company are mainly divided into four categories: refractive projects, cataract projects, medical optometry projects and comprehensive eye diseases projects. The number of myopia population in China ranks first in the world, but the penetration rate of refractive surgery is not high, and the market potential is huge in the future. The company has the whole process service ability, good reputation and brand effect advantages, and will occupy an advantage in the market competition. From 2017 to 2020, the company’s revenue CAGR was 19.13%, and the compound annual growth rate of net profit attributable to the parent company was 116.34%. With the raised funds put into operation, the company gradually improves its chain and information level, and further improves the company’s market competitiveness.
Chuangkeban:
Jijiyaokang (a21278. SH): the company provides customers with commercial mouse models with independent intellectual property rights, and carries out one-stop services such as model customization, customized breeding, functional and pharmacodynamic analysis. The market scale of preclinical drug R & D technical services in downstream industries is expected to increase. The national government and relevant departments have issued a series of policies to promote the healthy and rapid development of the industry. As an enterprise with first mover advantage and advanced technology, the company has more advantages than enterprises in the same industry. From 2018 to 2020, the company’s revenue CAGR was 121.70%, and the compound annual growth rate of net profit attributable to the parent company was 283.29%. With the raised funds put into operation, the company gradually improved its production capacity and R & D level, and further improved the company’s market competitiveness.
Jingsong intelligent (a04932. SH): the company is a provider of intelligent warehousing and logistics equipment and intelligent warehousing and logistics system, focusing on R & D and manufacturing of intelligent warehousing and logistics equipment, developing intelligent warehousing and logistics software, and providing intelligent warehousing and logistics system for downstream customers. The compound growth rates of the company’s operating revenue and net profit attributable to the parent company from 2018 to 2020 were 43.99% and 251.78% respectively. Intelligent logistics and storage equipment are widely used in the downstream (service manufacturing industry) and strongly supported by national policies. The market scale of the downstream industry is expected to further expand. The company has key core technologies, self-developed and self-produced key equipment, and has the ability to provide intelligent warehousing and logistics system solutions, so it will occupy an advantage in the future market competition. After the raised funds are put into operation, the company gradually improves its production capacity and R & D level to further improve the company’s market competitiveness.
Hechuan Technology (a21180. SH): the company is a technology driven provider of core components and overall solutions for industrial automation control, mainly engaged in the R & D, production, sales and application integration of industrial automation products. The compound annual growth rates of the company’s revenue and net profit from 2018 to 2020 were 38.65% and 45.84% respectively, and its development capacity was higher than the average level of comparable companies in the same industry. There is a certain market demand in the industry of industrial automation core components and solutions. In the future, the company’s investment in servo system and PLC design and R & D will continue to increase, and the fund-raising projects will significantly improve the company’s R & D, production and marketing capabilities, improve product capacity and enhance core competitiveness. The company is expected to further improve its industry strength and market position.
Jingye intelligence (a21273. SH): the company is a national high-tech enterprise specializing in nuclear industry Siasun Robot&Automation Co.Ltd(300024) and intelligent equipment. Its external sales products are mainly nuclear industry series Siasun Robot&Automation Co.Ltd(300024) , nuclear industry intelligent equipment, non nuclear special intelligent equipment, etc. In 20182020, the company’s operating revenue was 79.836 million yuan, 1006558 million yuan and 2063952 million yuan, with a three-year compound growth rate of 60.79%. Among them, nuclear industry intelligent equipment and nuclear industry series Siasun Robot&Automation Co.Ltd(300024) are the main sources of the company’s main business income, accounting for more than 80% on average. The company will benefit from the rapid growth of demand related to the nuclear industry and the policy dividend of intelligent manufacturing. In the future, the company is expected to take advantage of technological advantages and first mover advantages to take the lead in the competition and achieve further growth.?
Risk tips: 1) the corresponding companies still have the risk of failure to be listed due to special events; 2) The research is only based on the prospectus (Registration draft) and other public materials of the corresponding company, which can not fully reflect the latest situation of the company.
